Background: Thyroid cancer incidence continues to rise globally, yet current diagnostic methods, reliant on ultrasound-guided fine-needle aspiration, suffer from substantial inter-observer variability and indeterminate results. Objective: This review explores the transformative potential of integrated artificial intelligence (AI) foundation models in thyroid cancer management. We propose a paradigm shift using foundation models—large-scale, multimodal architectures pre-trained on diverse datasets—to bridge the gap between initial pixels and long-term prognostic prediction. Proposed Models: We introduce two integrated conceptual frameworks: ThyroSight-Prognos for high-precision assessment in specialized tertiary settings and SonoPredict-AI for cost-effective screening in primary care. Key Innovations: By synthesizing data from ultrasound, pathology (WSI), genomics, and clinical parameters through explainable AI (XAI), these models aim to reduce unnecessary surgeries and personalize treatment pathways. Challenges and Outlook: This paper addresses critical implementation challenges, including data heterogeneity, hardware requirements, and regulatory trust, ultimately providing a strategic blueprint for future multi-center prospective clinical validation to revolutionize thyroid care through precision oncology.
Park et al. (Fri,) studied this question.